TelyRx(TSX) TELY

Market CapCA$72.09MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2025)-10%
5 YearN/A
1 YearN/A
1 Month+8%
CA$2.65
-1.49%
-0.04Today
TelyRx last closing stock price
MetricPriceDate
Last closeCAD 2.692026-10-13
TelyRx stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+3.46%CAD 2.602026-10-06
1 month+8.47%CAD 2.482026-09-11
3 month-7.24%CAD 2.902026-07-15
Year to date-97.01%CAD 90.002025-10-31
Since inception-10.33%CAD 3.002025-10-31

TelyRx Financials at a Glance

Market Cap

CA$72.09MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$57.99

Net Income (TTM)

-CA$13.00

EPS (TTM)

-CA$18.62

P/E Ratio

-0.14

Dividend

CA$0.00

Beta (Volatility)

-0.73 (Low)

Price

CA$2.65

Volume

25,050

Open

CA$2.72

Previous Close

CA$2.65

Daily Range

CA$2.65 - CA$2.75

52-Week Range

CA$2.00 - CA$90.00

Estimated Earnings Date

Dec 2, 2026

TELY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About TelyRx

TelyRx Holdings Inc. operates as a vertically integrated technology-enabled healthcare and pharmacy services company. The company develops a digital pharmacy platform that connects patients with physicians for everyday prescriptions, ensuring next-day delivery of medications.

Products and Services
  • Digital pharmacy platform connecting patients and physicians
  • Next-day delivery service for prescriptions
  • Services for doctors, veterinarians, and licensed prescribers
Growth Outlook
  • Market demand for telehealth services is increasing
  • Expansion plans to enhance service offerings nationwide
  • Focus on technology integration to improve patient experience
Financial Highlights
  • Market capitalization of approximately CAD 65.9 million
  • Stock price range between CAD 2 and CAD 4.25 over the year
  • Low beta of 0.071 indicates stability compared to the market
TelyRx Holdings Inc. is positioned in the growing healthcare sector, particularly in telehealth and digital pharmacy services. The company's innovative platform addresses the increasing demand for convenient access to prescriptions, which is becoming essential in today's healthcare landscape. With a focus on technology and patient experience, TelyRx aims to expand its reach and enhance its service offerings. The financial metrics indicate a stable market presence, making it an intriguing option for potential investors interested in the healthcare and pharmaceutical industries.
AI Generated • Oct 2, 2026

Industry

Food and Staples Retailing

Sector

Consumer Staples

CEO

Vanessa Slowey

Website

telyrx.com

Headquarters

Clearwater, FL 33763, US

TELY Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

-159.46%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

-7.14%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

CA$72.09MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

26.80M

Volume

25.05K

Avg. Volume

22.33K

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

TelyRx Performance Analysis

TelyRx annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20252025-12-31CAD 0N/A
TelyRx annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20252025-12-31CAD -1.59N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

CA$31.38

N/A

Gross Profit

CA$17.59

N/A

Gross Margin

56.06%

N/A

Market Cap

CA$72.09MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

-CA$6.19

+211.7%

EBITDA

-CA$7.12

+243.8%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

CA$50.55

+5790.9%

Total Debt

CA$19.13

N/A

Accounts Receivable

CA$0.97

N/A

Inventory

CA$2.16

N/A

Long Term Debt

CA$17.86

N/A

Short Term Debt

CA$1.27

N/A

Return on Assets

-58.21%

N/A

Return on Invested Capital

-29.18%

N/A

Free Cash Flow

-CA$6.19

N/A

Operating Cash Flow

-CA$5.90

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,709.28-0.01%
^DJIDJI
$51,466.30-0.00%
^IXICNASDAQ
$26,684.28-0.02%
BTCBitcoin
$81,564.00-0.02%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$221.30-3.16%
BACBank of America
$51.39-4.76%
CRWVCoreWeave
$65.78-15.46%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$110.54-13.35%

Questions About TELY

What is the current price of TelyRx?

TelyRx is trading at CA$2.65 per share.

What is the 52-week range for TelyRx?

Over the past 52 weeks, TelyRx has traded between CA$2.00 and CA$90.00.

How much debt does TelyRx have?

As of the most recent reporting period, TelyRx reported total debt of CA$19.13M.

How much cash does TelyRx have on hand?

TelyRx reported CA$31.42M in cash and cash equivalents in its most recent financial results.

What is TelyRx’s dividend yield?

TelyRx does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services